{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:45:07Z","timestamp":1740163507678,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated for the first time brain ischemic involvement in 19 consecutive neurologically asymptomatic PNH patients by non-enhanced cerebral MRI, and by intracranial arterial and venous angio-MRI. Eleven cases (58%, 7 aged &lt;65) showed pathological findings: 9 white matter (WM) abnormalities related to chronic ischemic small vessel disease, 2 a focal abnormality &gt;5\u2009mm, and 5 cases a score &gt;4 by the age-related white matter changes (ARWMC) scale. Compared with age and sex-matched controls (1:2 ratio), patients showed an increased frequency of periventricular WM vascular degeneration (32% versus 5.2%, p\u2009=\u20090.04) and of severe lesions (ARWMC scale score <jats:underline>&gt;<\/jats:underline>4) (26% versus 2.6%, p\u2009=\u20090.05), and a higher overall ARWMC scale score (3.5\u2009\u00b1\u20091.07 versus 2.0\u2009\u00b1\u20090.8, mean\u2009\u00b1\u2009SD, p\u2009&lt;\u20090.0001). Notably, vascular abnormalities suspected for prior partial venous thrombosis, were observed in PNH cases only. MRI lesions were not related to blood counts, hemolytic markers, clone size, disease duration, and therapy with eculizumab. Neurological examination was unremarkable in all patients but one (Parkinson disease). Psychiatric assessment revealed a case of generalized anxiety disorder, 1 bipolar disorder type 2, and 1 adjustment disorder. In conclusion, brain MRI may be useful at diagnosis and during the course of the disease to explore subclinical neurological involvement.<\/jats:p>","DOI":"10.1038\/s41598-017-18936-0","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T11:46:18Z","timestamp":1515152778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Paroxysmal Nocturnal Hemoglobinuria (Pnh): Brain Mri Ischemic Lesions In Neurologically Asymtomatic Patients"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-9944","authenticated-orcid":false,"given":"Wilma","family":"Barcellini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Scola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Lanfranconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Grottaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Binda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fattizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zaninoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Valcamonica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Maria","family":"Cinnante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Boschetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Buoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Alfredo","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nereo","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Triulzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"18936_CR1","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill, A., DeZern, A. E., Kinoshita, T. & Brodsky, R. A. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers 3, 17028, https:\/\/doi.org\/10.1038\/nrdp.2017.28 (2017).","journal-title":"Nat Rev Dis Primers"},{"key":"18936_CR2","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill, A., Kelly, R. J. & Hillmen, P. Thrombosis in paroxysmal nocturnal haemoglobinuria. Blood 121, 4985\u20134996, https:\/\/doi.org\/10.1182\/blood-2012-09-311381 (2013).","journal-title":"Blood"},{"key":"18936_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2141.2010.08505.x","volume":"152","author":"Y Kozuma","year":"2011","unstructured":"Kozuma, Y. et al. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol 152, 631\u2013639, https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08505.x (2011).","journal-title":"Br J Haematol"},{"key":"18936_CR4","doi-asserted-by":"publisher","unstructured":"Brodsky, R. A. Complement in haemolytic anaemia. Blood (Haematology American Society of Haematology, Educational Program 385\u2013391, https:\/\/doi.org\/10.1182\/asheducation-2015.1.385 (2015).","DOI":"10.1182\/asheducation-2015.1.385"},{"key":"18936_CR5","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP de Latour","year":"2008","unstructured":"de Latour, R. P. et al. French Society of Hematology; French Association of Young Hematologists. Paroxysmal nocturnal haemoglobinuria: natural history of disease subcategories. Blood 112, 3099\u20133106, https:\/\/doi.org\/10.1182\/blood-2008-01-133918 (2008).","journal-title":"Blood"},{"key":"18936_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2013.093161","volume":"99","author":"H Schrezenmeier","year":"2014","unstructured":"Schrezenmeier, H. et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Haemoglobinuria Registry. Haematologica 99, 922\u2013929, https:\/\/doi.org\/10.3324\/haematol.2013.093161 (2014).","journal-title":"Haematologica"},{"key":"18936_CR7","doi-asserted-by":"publisher","unstructured":"Luzzatto L. Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria. F1000Res 5, https:\/\/doi.org\/10.12688\/f1000research.7288.1 (eCollection 2016).","DOI":"10.12688\/f1000research.7288.1"},{"key":"18936_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"21","author":"P Hillmen","year":"2006","unstructured":"Hillmen, P. et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. New EngL J Med 21, 1233\u20131243, https:\/\/doi.org\/10.1056\/NEJMoa061648 (2006).","journal-title":"New EngL J Med"},{"key":"18936_CR9","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen, P. et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110, 4123\u20134128, https:\/\/doi.org\/10.1182\/blood-2007-06-095646 (2007).","journal-title":"Blood"},{"key":"18936_CR10","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"111","author":"RA Brodsky","year":"2008","unstructured":"Brodsky, R. A. et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111, 1840\u20131847, https:\/\/doi.org\/10.1182\/blood-2007-06-094136 (2008).","journal-title":"Blood"},{"key":"18936_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","volume":"149","author":"A Hill","year":"2010","unstructured":"Hill, A. et al. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 149, 414\u2013425, https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08096.x (2010).","journal-title":"Br J Haematol"},{"key":"18936_CR12","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly, R. J. et al. Long-term treatment with eculizumab in paroxysmal nocturnal haemoglobinuria: sustained efficacy and improved survival. Blood 117, 6786\u20136792, https:\/\/doi.org\/10.1182\/blood-2011-02-333997 (2011).","journal-title":"Blood"},{"key":"18936_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ajh.24278","volume":"91","author":"M Loschi","year":"2016","unstructured":"Loschi, M. et al. Impact of eculizumab treatment on paroxysmal nocturnal haemoglobinuria: a treatment versus no-treatment study. Am J Hematol 91, 366\u2013370, https:\/\/doi.org\/10.1002\/ajh.24278 (2016).","journal-title":"Am J Hematol"},{"key":"18936_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1017\/S0317167100006855","volume":"34","author":"NJ Samadder","year":"2007","unstructured":"Samadder, N. J., Casaubon, L., Silver, F. & Cavalcanti, R. Neurological complications of paroxysmal nocturnal haemoglobinuria. Can J Neurol Sci 34, 368\u2013371, https:\/\/doi.org\/10.1017\/S0317167100006855 (2007).","journal-title":"Can J Neurol Sci"},{"key":"18936_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1755-7682-7-39","volume":"7","author":"AR Memon","year":"2014","unstructured":"Memon, A. R., Khan, R., Rauf, M. U. & Shafique, K. Paroxysmal nocturnal haemoglobinuria presenting as cerebral venous sinus thrombosis: a case report. Int Arch Med 7, 39, https:\/\/doi.org\/10.1186\/1755-7682-7-39 (2014).","journal-title":"Int Arch Med"},{"key":"18936_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0972-5229.175948","volume":"20","author":"GS Shrestha","year":"2016","unstructured":"Shrestha, G. S. et al. Cerebral venous thrombosis presenting with intracerebral haemorrhage in a patient with paroxysmal nocturnal haemoglobinuria. Indian J Crit Care Med 20, 117\u2013119, https:\/\/doi.org\/10.4103\/0972-5229.175948 (2016).","journal-title":"Indian J Crit Care Med"},{"key":"18936_CR17","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1097\/MD.0000000000000362","volume":"94","author":"E Meppiel","year":"2015","unstructured":"Meppiel, E. et al. Cerebral Venous Thrombosis in Paroxysmal Nocturnal Haemoglobinuria A Series of 15 Cases and Review of the Literature. Medicine (Baltimore) 94, e362, https:\/\/doi.org\/10.1097\/MD.0000000000000362 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"18936_CR18","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00415-005-0871-3","volume":"252","author":"HJ Audebert","year":"2005","unstructured":"Audebert, H. J. et al. Cerebral ischemic infarction in paroxysmal nocturnal haemoglobinuria report of 2 cases and updated review of 7 previously published patients. J Neurol 252, 1379\u20131386, https:\/\/doi.org\/10.1007\/s00415-005-0871-3 (2005).","journal-title":"J Neurol"},{"key":"18936_CR19","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.001","volume":"26","author":"AT Meira","year":"2017","unstructured":"Meira, A. T. et al. Multiple Lacunar Infarcts in Paroxysmal Nocturnal Hemoglobinuria. J Stroke Cerebrovasc Dis 26, e199\u2013e202, https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.07.001 (2017).","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"18936_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11604-009-0412-6","volume":"28","author":"S Mugikura","year":"2010","unstructured":"Mugikura, S. et al. Unilateral moyamoya syndrome involving the ipsilateral anterior and posterior circulation associated with paroxysmal nocturnal haemoglobinuria. Jpn J Radiol 28, 243\u2013246, https:\/\/doi.org\/10.1007\/s11604-009-0412-6 (2010).","journal-title":"Jpn J Radiol"},{"key":"18936_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/pbc.24070","volume":"59","author":"TA Yen","year":"2012","unstructured":"Yen, T. A. et al. Eculizumab treatment of paroxysmal nocturnal haemoglobinuria presenting as moyamoya syndrome in a 9-year-old male. Pediat Blood Cancer 59, 203\u2013204, https:\/\/doi.org\/10.1002\/pbc.24070 (2012).","journal-title":"Pediat Blood Cancer"},{"key":"18936_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12185-013-1346-4","volume":"97","author":"JW Lee","year":"2013","unstructured":"Lee, J. W. et al. Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal haemoglobinuria from a Korean Registry. Int J Haematol 97, 749\u2013757, https:\/\/doi.org\/10.1007\/s12185-013-1346-4 (2013).","journal-title":"Int J Haematol"},{"key":"18936_CR23","doi-asserted-by":"publisher","unstructured":"De Cobelli, F. et al. New Insights in Abdominal Pain in Paroxysmal Nocturnal Haemoglobinuria (PNH): A MRI Study. PLoS One, 10, e0122832, https:\/\/doi.org\/10.1371\/journal.pone.0122832 (ecollection 2015).","DOI":"10.1371\/journal.pone.0122832"},{"key":"18936_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/jnnp.2008.154104","volume":"80","author":"NK Oksala","year":"2009","unstructured":"Oksala, N. K. et al. Age related white matter changes predict stroke death in long term follow-up. J Neurol, Neurosur, and psychiatry 80, 762\u2013766, https:\/\/doi.org\/10.1136\/jnnp.2008.154104 (2009).","journal-title":"J Neurol, Neurosur, and psychiatry"},{"key":"18936_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.neurobiolaging.2006.06.010","volume":"28","author":"LH Kuller","year":"2007","unstructured":"Kuller, L. H. et al. White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol Aging 28, 1307\u20131315, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.06.010 (2007).","journal-title":"Neurobiol Aging"},{"key":"18936_CR26","doi-asserted-by":"publisher","unstructured":"Quinn, C.T. Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease. Blood (American Society of Haematology Educational Program), 438\u2013443, https:\/\/doi.org\/10.1182\/asheducation-2014.1.438 (2014).","DOI":"10.1182\/asheducation-2014.1.438"},{"key":"18936_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00234-013-1176-3","volume":"55","author":"K Weissenborn","year":"2013","unstructured":"Weissenborn, K. et al. Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI. Neuroradiol 55, 819\u2013825, https:\/\/doi.org\/10.1007\/s00234-013-1176-3 (2013).","journal-title":"Neuroradiol"},{"key":"18936_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2016.1193966","volume":"20","author":"G Abe","year":"2016","unstructured":"Abe, G., Kikuchi, H., Arinuma, Y. & Hirohata, S. Brain MRI in patients with acute confusional state of diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus. Mod Rheumatol 20, 1\u20136, https:\/\/doi.org\/10.1080\/14397595.2016.1193966 (2016).","journal-title":"Mod Rheumatol"},{"key":"18936_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000443750","volume":"41","author":"I Gonz\u00e1lez-Su\u00e1rez.","year":"2016","unstructured":"Gonz\u00e1lez-Su\u00e1rez., I., Arpa, J. & R\u00edos-Blanco, J. J. Brain Microvasculature Involvement in ANCA Positive Vasculitis. Cerebrovasc Dis 41, 313\u2013321, https:\/\/doi.org\/10.1159\/000443750 (2016).","journal-title":"Cerebrovasc Dis"},{"key":"18936_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1212\/WNL.0000000000000188","volume":"82","author":"RS Mackin","year":"2014","unstructured":"Mackin, R. S. et al. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology 82, 835\u201341, https:\/\/doi.org\/10.1212\/WNL.0000000000000188 (2014). Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group.","journal-title":"Neurology"},{"key":"18936_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/bjh.13962","volume":"176","author":"R Manara","year":"2017","unstructured":"Manara, R. et al. Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease. Br J Haematol 176, 485\u2013487, https:\/\/doi.org\/10.1111\/bjh.13962 (2017).","journal-title":"Br J Haematol"},{"key":"18936_CR32","doi-asserted-by":"publisher","unstructured":"Colombatti, R. et al. Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study. PLoS One, 11, e0157090, https:\/\/doi.org\/10.1371\/journal.pone.0157090 (ecollection 2016).","DOI":"10.1371\/journal.pone.0157090"},{"key":"18936_CR33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund, L. O. et al. European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318\u20131322, https:\/\/doi.org\/10.1161\/01.STR.32.6.1318 (2001).","journal-title":"Stroke"},{"key":"18936_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw, J. M. et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVEv1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12, 822\u201338, https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8 (2013).","journal-title":"Lancet Neurol"},{"key":"18936_CR35","unstructured":"American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revised. (American Psychiatric Press: Washington D.C. 2000)."},{"key":"18936_CR36","unstructured":"First, M.B., Spitzer, R.L., Gibbon, M. & Williams, J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I\/P). (Biometrics Research, New York State Psychiatric Institute (2002)."},{"key":"18936_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1192\/bjp.187.4.366","volume":"187","author":"S Leucht","year":"2005","unstructured":"Leucht, S. et al. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry 187, 366\u2013371, https:\/\/doi.org\/10.1192\/bjp.187.4.366 (2005).","journal-title":"Br J Psychiatry"},{"key":"18936_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","volume":"51","author":"G Apolone","year":"1998","unstructured":"Apolone, G. & Mosconi, P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51, 1025\u20131036, https:\/\/doi.org\/10.1016\/S0895-4356(98)00094-8 (1998).","journal-title":"J Clin Epidemiol"},{"key":"18936_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2466\/pms.1970.30.1.319","volume":"30","author":"WR Goul","year":"1970","unstructured":"Goul, W. R. & Brown, M. Effects of age and intelligence on trail making test performance and validity. Percep Mot Skills 30, 319\u2013326, https:\/\/doi.org\/10.2466\/pms.1970.30.1.319 (1970).","journal-title":"Percep Mot Skills"},{"key":"18936_CR40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1600-0609.2007.00844.x","volume":"78","author":"Z Zhou","year":"2007","unstructured":"Zhou, Z. et al. Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China. Eur J Hematol 78, 518\u2013523, https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00844.x (2007).","journal-title":"Eur J Hematol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18936-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18936-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18936-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:55:24Z","timestamp":1671846924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18936-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18936"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18936-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,1,11]]},"assertion":[{"value":"30 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"476"}}